Showing results (61-70 of 193) with videos related to

Sort By:
Pageof 20
European Journal of Medicinal Chemistry|March 8, 2020
Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicityXuan Zhang, Dinesh Thummuri, Xingui Liu, et al.
Aging Cell|February 19, 2019
Elimination of senescent osteoclast progenitors has no effect on the age-associated loss of bone mass in miceHa-Neui Kim, Jianhui Chang, Srividhya Iyer, et al.
Scientific Reports|August 27, 2020
Depletion of senescent-like neuronal cells alleviates cisplatin-induced peripheral neuropathy in miceScarlett Acklin, Manchao Zhang, Wuying Du, et al.
Cancers|March 28, 2026
The Combination of a BCL-xL PROTAC and an mTOR Inhibitor Sensitizes Pancreatic Ductal Adenocarcinoma to KRASG12D Inhibitor TreatmentJaved Miyan, Vignesh Vudatha, Lin Cao, et al.
Analytical Chemistry|October 2, 2025
Machine Learning-Assisted Terahertz Metagrating Biosensor for Label-Free Bacterial Identification Based on Spectral FingerprintingWenjing Yu, Yupeng Long, Junjie Luo, et al.
Cell & Bioscience|November 27, 2015
Granulocyte colony-stimulating factor exacerbates hematopoietic stem cell injury after irradiationChengcheng Li, Lu Lu, Junling Zhang, et al.
JCI Insight|March 14, 2023
Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicitySiyao Li, Man J Livingston, Zhengwei Ma, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancerSajid Khan, Lin Cao, Janet Wiegand, et al.
Aging and Cancer|October 3, 2022
Cancer and aging: A call to actionDejana Braithwaite, Stephen Anton, Supriya Mohile, et al.
Radiation Research|June 1, 2016
Hematopoietic Stem Cells from Ts65Dn Mice Are Deficient in the Repair of DNA Double-Strand BreaksYingying Wang, Jianhui Chang, Lijian Shao, et al.
Pageof 20